Form 4: HealthStream EVP Granted Equity Awards

HealthStream's Executive Vice President, Michael Manning Collier, was granted 3,134 restricted share units and 9,402 stock options on December 9, 2025.

Summary

• Michael Manning Collier, Executive Vice President of HealthStream Inc. (HSTM), reported beneficial ownership of 50,981 shares of common stock.
• On December 9, 2025, Collier was granted 3,134 Restricted Share Units (RSUs). Each RSU represents the contingent right to receive one share of common stock upon vesting.
• The RSUs are subject to a four-year vesting schedule, contingent upon continued service: 15% vest on December 9, 2026, 20% on December 9, 2027, 30% on December 9, 2028, and the remaining 35% on December 9, 2029.
• On the same date, Collier was granted 9,402 Employee Stock Options with an exercise price of $23.93 per share and an expiration date of December 9, 2035.
• The stock options also follow a four-year vesting schedule, contingent upon continued service, identical to the RSUs: 15% vest on December 9, 2026, 20% on December 9, 2027, 30% on December 9, 2028, and 35% on December 9, 2029.
• The transactions were made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 7

Explanation: The equity grants are a positive for executive retention and alignment of interests with shareholders, reflecting standard compensation practices. It does not directly impact immediate financial performance but supports long-term stability.

Positives

• The grant of restricted share units and stock options aligns the Executive Vice President's long-term interests with those of shareholders, incentivizing sustained company performance.
• The vesting schedule, contingent on continued service, promotes executive retention and commitment to the company's future.

Negatives

• The equity awards are subject to a multi-year vesting schedule, meaning the shares and options are not immediately liquid or fully owned by the executive.

Risks

• Vesting of both restricted share units and stock options is contingent upon continued service, meaning the executive must remain employed to realize the full benefit.
• The value of the stock options and restricted share units is subject to the future performance and market price fluctuations of HealthStream's common stock.

Future Outlook

The equity grants, with their multi-year vesting schedules, indicate a long-term incentive structure for the Executive Vice President, aligning future performance with shareholder value creation over the next four years and beyond for the options.

Industry Context

The granting of restricted share units and stock options to key executives is a standard practice across various industries, particularly in technology and healthcare sectors, to attract, retain, and motivate talent while aligning their financial interests with the company's long-term success.

Comparison to Industry Standards

• The use of a combination of restricted share units and stock options for executive compensation is a common practice, comparable to long-term incentive plans observed in many publicly traded companies.
• The four-year vesting schedule is typical for such equity grants, providing a balance between immediate incentive and long-term retention, similar to plans at peer companies in the healthcare technology space.

Corporate Governance

Stakeholder Impact

• Shareholders: The equity grants align the Executive Vice President's financial incentives with the long-term performance of the company, potentially leading to increased shareholder value.
• Employees: The compensation structure for a key executive can influence overall employee morale and perception of the company's commitment to its leadership.

Next Steps

• The vesting of the granted Restricted Share Units and Employee Stock Options will occur in tranches on December 9, 2026, 2027, 2028, and 2029, contingent on continued service.

Key Dates

Recommendation

This Form 4 filing details routine equity grants to a key executive, which is a standard component of executive compensation designed to align management's interests with long-term shareholder value. While positive for executive retention and motivation, it does not present new information that would fundamentally alter the company's financial outlook or warrant a change in an existing investment thesis. Therefore, a 'hold' recommendation is appropriate, maintaining current positions based on broader company fundamentals.

Keywords

HealthStream, HSTM, SEC Form 4, Insider Transaction, Equity Grant, Restricted Stock Units, Stock Options, Executive Compensation, Rule 10b5-1